These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 23172086)
1. Histopathological features of cutaneous drug reactions to vemurafenib: a report of two cases. Dabner M; Harvey NT; Soma A; Wood BA Pathology; 2012 Dec; 44(7):661-4. PubMed ID: 23172086 [No Abstract] [Full Text] [Related]
2. Second primary melanomas on treatment with vemurafenib. Dalle S; Poulalhon N; Debarbieux S; Thomas L Br J Dermatol; 2013 Apr; 168(4):887-8. PubMed ID: 23066856 [No Abstract] [Full Text] [Related]
3. Cutaneous manifestations of vemurafenib therapy for metastatic melanoma. Owen JL; Lopez IE; Desai SR J Drugs Dermatol; 2015 May; 14(5):509-10. PubMed ID: 25942671 [TBL] [Abstract][Full Text] [Related]
4. Induction vemurafenib followed by consolidative radiation therapy for surgically incurable melanoma. Seeley AR; De Los Santos JF; Conry RM Melanoma Res; 2015 Jun; 25(3):246-51. PubMed ID: 25746037 [TBL] [Abstract][Full Text] [Related]
5. Multiple white cysts on face and trunk of a melanoma patient treated with vemurafenib. Gebhardt C; Staub J; Schmieder A; Goerdt S; Utikal J Acta Derm Venereol; 2015 Jan; 95(1):96-7. PubMed ID: 24710689 [No Abstract] [Full Text] [Related]
6. Cutaneous toxicities associated with vemurafenib therapy in 107 patients with BRAF V600E mutation-positive metastatic melanoma, including recognition and management of rare presentations. Sinha R; Larkin J; Gore M; Fearfield L Br J Dermatol; 2015 Oct; 173(4):1024-31. PubMed ID: 26109403 [TBL] [Abstract][Full Text] [Related]
7. Second primary melanomas on treatment with vemurafenib: reply from the authors. Fearfield L; Newton-Bishop JA; Sinha R; Edmonds K; Gore ME; Larkin J Br J Dermatol; 2013 Apr; 168(4):888-9. PubMed ID: 23066884 [No Abstract] [Full Text] [Related]
8. Vemurafenib: a guide to its use in unresectable or metastatic melanoma. Keating GM; Lyseng-Williamson KA Am J Clin Dermatol; 2013 Feb; 14(1):65-9. PubMed ID: 23329082 [TBL] [Abstract][Full Text] [Related]